Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
periodontitis pharyngitis gingivitis amalgam fluoride mutans pulp candidiasis pulp malocclusionYour Article Summary
See Latest ArticlesLongitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Journal of Clinical Oncology, 10/12/09
Vahtsevanos K et al. – The conclusions of this study validated dental extractions and use of dentures as risk factors for ONJ development. Ibandronate and pamidronate at the dosages and frequency used in this study seem to exhibit a safer drug profile concerning ONJ complication; however, randomized controlled trials are needed to validate these results. Before initiation of a bisphosphonate, patients should have a comprehensive dental examination. Patients with a challenging dental situation should have dental care attended to before initiation of these drugs.
Athanassios Kyrgidis, 10/13/09
| Smoking, periodontitis, and root canal treatment did not increase risk for ONJ in patients receiving bisphosphonates. CPITN was not a predictor for ONJ development. Based on presented evidence, we concluded that it is the number of zoledronate doses that confers a higher risk for ONJ development and not the number of bisphosphonate doses in general. The data derived from the present study concern patients with multiple myeloma, breast cancer, and prostate cancer. However, they could also apply to patients with lung cancer who will survive beyond their life expectancy. ONJ does not seem to be less frequent among patients with breast cancer when controlled for possible confounders. |
Today in OMF Pathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09
Oral Cancer Prevention Advances with a Translational Trial of Green Tea
Cancer Prevention Research, 11/10/09
Autofluorescence-Guided Surveillance for Oral Cancer
Cancer Prevention Research, 11/10/09
Today in Orthodontics/Dentofacial...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of 0.50% and 0.75% chlorhexidine dentifrices in orthodontic patients: A double-blind and randomized controlled trial
American Journal of Orthodontics and Dentofacial Orthopedics, 11/10/09
Asymmetry of the lips of orthognathic surgery patients
American Journal of Orthodontics and Dentofacial Orthopedics, 10/30/09
Effects of preoperative ibuprofen on pain after separator placement
American Journal of Orthodontics and Dentofacial Orthopedics, 10/29/09
Article Search
Sponsor